Journal article icon

Journal article

VEGF‐A inhibits agonist‐mediated Ca2+ responses and activation of IKCa channels in mouse resistance artery endothelial cells

Abstract:
Vascular endothelial growth factor A (VEGF‐A) is a potent permeability and angiogenic factor that is also associated with the remodelling of the microvasculature. Elevated VEGF‐A levels are linked to a significant increase in the risk of cardiovascular dysfunction, although it is unclear how VEGF‐A has a detrimental, disease‐related effect. Small resistance arteries are central determinants of peripheral resistance and endothelium‐dependent hyperpolarization (EDH) is the predominant mechanism by which these arteries vasodilate. Using isolated, pressurized resistance arteries, we demonstrate that VEGF‐A acts via VEGF receptor‐2 (R2) to inhibit both endothelial cell (EC) Ca2+ release and the associated EDH vasodilatation mediated by intermediate conductance Ca2+‐activated K+ (IKCa) channels. Importantly, VEGF‐A had no direct effect against IKCa channels. Instead, the inhibition was crucially reliant on the downstream activation of the mitogen‐activated protein/extracellular signal‐regulated kinase kinase 1/2 (MEK1/2). The distribution of EC inositol 1,4,5‐trisphosphate (IP3) receptor‐1 (R1) was not affected by exposure to VEGF‐A and we propose an inhibition of IP3R1 through the MEK pathway, probably via ERK1/2. Inhibition of EC Ca2+ via VEGFR2 has profound implications for EDH‐mediated dilatation of resistance arteries and could provide a mechanism by which elevated VEGF‐A contributes towards cardiovascular dysfunction.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1113/JP275793

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Pharmacology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Pharmacology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Oxford college:
Magdalen College
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Pharmacology
Role:
Author


More from this funder
Funding agency for:
Dora, K
Grant:
Senior Basic Science Research Fellow
PG/14/58/30998
FS/13/16/30199


Publisher:
Wiley
Journal:
Journal of Physiology More from this journal
Volume:
596
Issue:
16
Pages:
3553-3566
Publication date:
2018-06-03
Acceptance date:
2018-05-15
DOI:
ISSN:
0022-3751


Keywords:
Pubs id:
pubs:891041
UUID:
uuid:c97dbb18-9ab0-4df6-ae19-e705e3da92ae
Local pid:
pubs:891041
Source identifiers:
891041
Deposit date:
2018-07-24

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP